Systems immunology reveals markers of susceptibility to west Nile virus infection http://cvi.asm.org/content/22/1/6.full.pdf+html

Clinical and Vaccine Immunology

Volumn 22, Issue 1, 2015, Pages 6-16

  Qian, Feng ^a   Goel, Gautam ^b   Meng, Hailong ^a   Wang, Xiaomei ^a   You, Fuping ^a   Devine, Lesley ^a   Raddassi, Khadir ^a   Garcia, Melissa N ^d   Murray, Kristy O ^d   Bolen, Christopher R ^a   Gaujoux, Renaud ^e   Shen Orr, Shai S ^e   Hafler, David ^a   Fikrig, Erol ^a,c   Xavier, Ramnik ^b   Kleinstein, Steven H ^a   Montgomery, Ruth R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; CXCL10 PROTEIN, HUMAN; GENETIC MARKER;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; EX VIVO STUDY; FEMALE; FLAVIVIRUS INFECTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; INFECTION; INFECTION SENSITIVITY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MYELOID DENDRITIC CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; VERY ELDERLY; WEST NILE FLAVIVIRUS; WEST NILE VIRUS INFECTION; BIOSYNTHESIS; DISEASE PREDISPOSITION; GENE EXPRESSION PROFILING; GENETIC MARKER; MIDDLE AGED; PROCEDURES; SYSTEMS BIOLOGY; WEST NILE VIRUS; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CHEMOKINE CXCL10; DISEASE SUSCEPTIBILITY; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; SYSTEMS BIOLOGY; TRANSCRIPTION, GENETIC; WEST NILE VIRUS; YOUNG ADULT;

EID: 84920511159     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00508-14     Document Type: Article

References (49)

1. Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li GM, McCausland M, Kanchan V, Kokko KE, Li S, Elbein R, Mehta AK, Aderem A, Subbarao K, Ahmed R, Pulendran B. 2011. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 12: 786-795. http://dx.doi.org/10.1038/ni.2067.
2. Furman D, Jojic V, Kidd B, Shen-Orr S, Price J, Jarrell J, Tse T, Huang H, Lund P, Maecker HT, Utz PJ, Dekker CL, Koller D, Davis MM. 2013. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol 9: 659. http://dx.doi.org/10.1038/msb.2013.15.
3. Obermoser G, Presnell S, Domico K, Xu H, Wang Y, Anguiano E, Thompson-Snipes L, Ranganathan R, Zeitner B, Bjork A, Anderson D, Speake C, Ruchaud E, Skinner J, Alsina L, Sharma M, Dutartre H, Cepika A, Israelsson E, Nguyen P, Nguyen QA, Harrod AC, Zurawski SM, Pascual V, Ueno H, Nepom GT, Quinn C, Blankenship D, Palucka K, Banchereau J, Chaussabel D. 2013. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38: 831-844. http://dx.doi.org/10.1016/j.immuni.2012.12.008.
4. Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B. 2014. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 15: 195-204. http://dx.doi.org/10.1038/ni.2789.
5. Sekiguchi DR, Smith SB, Sutter JA, Goodman NG, Propert K, Louzoun Y, Rogers W, Luning Prak ET. 2011. Circulating lymphocyte subsets in normal adults are variable and can be clustered into subgroups. Cytom B Clin Cytom 80: 291-299. http://dx.doi.org/10.1002/cyto.b.20594.
6. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. 2003. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100: 1896-1901. http://dx.doi.org/10.1073/pnas.252784499.
7. Colpitts TM, Conway MJ, Montgomery RR, Fikrig E. 2012. West Nile virus: biology, transmission and human infection. Clin Microbiol Rev 25: 635-648. http://dx.doi.org/10.1128/CMR.00045-12.
8. Petersen LR, Carson PJ, Biggerstaff BJ, Custer B, Borchardt SM, Busch MP. 2013. Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol Infect 141: 591-595. http://dx.doi.org/10.1017/S0950268812001070.
9. Suthar MS, Brassil MM, Blahnik G, McMillan A, Ramos HJ, Proll SC, Belisle SE, Katze MG, Gale M, Jr. 2013. A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog 9: e1003168. http://dx.doi.org/10.1371/journal.ppat.1003168.
10. Brien JD, Uhrlaub JL, Nikolich-Zugich J. 2008. West Nile virus-specificCD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol 181: 8568-8575. http://dx.doi.org/10.4049/jimmunol.181.12.8568.
11. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77: 2578-2586. http://dx.doi.org/10.1128/JVI.77.4.2578-2586.2003.
12. Kong K-F, Delroux K, Wang X, Qian F, Arjona A, Malawista SE, Fikrig E, Montgomery RR. 2008. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol 82: 7613-7623. http://dx.doi.org/10.1128/JVI.00618-08.
13. Brien JD, Uhrlaub JL, Hirsch A, Wiley CA, Nikolich-Zugich J. 2009. Key role of T cell defects in age-related vulnerability to West Nile virus. J Exp Med 206: 2735-2745. http://dx.doi.org/10.1084/jem.20090222.
14. Qian F, Wang X, Zhang L, Lin A, Zhao H, Fikrig E, Montgomery RR. 2011. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis 203: 1415-1424. http://dx.doi.org/10.1093/infdis/jir048.
15. Qian F, Thakar J, Yuan X, Nolan M, Murray KO, Lee WT, Wong SJ, Meng H, Fikrig E, Kleinstein SH, Montgomery RR. 2014. Immune markers associated with host susceptibility to infection with West Nile virus. Viral Immunol 27: 39-47. http://dx.doi.org/10.1089/vim.2013.0074.
16. Brusic V, Gottardo R, Kleinstein SH, Davis MM, HIPC Steering Committee. 2014. Computational resources for high-dimensional immune analysis from the Human Immunology Project Consortium. Nat Biotechnol 32: 146-148. http://dx.doi.org/10.1038/nbt.2777.
17. Nolan MS, Schuermann J, Murray KO. 2013. West Nile virus infection among humans, Texas, USA, 2002-2011. Emerg Infect Dis 19: 137-139. http://dx.doi.org/10.3201/eid1901.121135.
18. Qian F, Chung L, Zheng W, Bruno VM, Alexander RP, Wang Z, Wang X, Kurscheid S, Zhao H, Fikrig E, Gerstein M, Snyder M, Montgomery RR. 2013. Identification of genes critical for resistance to infection by West Nile virus using RNA-Seq analysis. Viruses 5: 1664-1681. http://dx.doi.org/10.3390/v5071664.
19. Anderson JF, Andreadis TG, Vossbrinck CR, Tirrell S, Wakem EM, French RA, Garmendia AE, Van Kruiningen HJ. 1999. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science 286: 2331-2333. http://dx.doi.org/10.1126/science.286.5448.2331.
20. Gould LH, Sui J, Foellmer H, Oliphant T, Wang T, Ledizet M, Murakami A, Noonan K, Lambeth C, Kar K, Anderson JF, de Silva AM, Diamond MS, Koski RA, Marasco WA, Fikrig E. 2005. Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J Virol 79: 14606-14613. http://dx.doi.org/10.1128/JVI.79.23.14606-14613.2005.
21. Sultana H, Neelakanta G, Foellmer HG, Montgomery RR, Anderson JF, Koski RA, Medzhitov RM, Fikrig E. 2012. Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signaling. J Immunol 189: 3150-3158. http://dx.doi.org/10.4049/jimmunol.1201140.
22. Maecker HT, McCoy JP, Nussenblatt R. 2012. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol 12: 191-200. http://dx.doi.org/10.1038/nri3158.
23. Du P, Kibbe WA, Lin SM. 2008. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548. http://dx.doi.org/10.1093/bioinformatics/btn224.
24. Smyth GK. 2005. Limma: linear models for microarray data, p 397-420. In Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (ed), Bioinformatics and computational biology solutions using R and Bioconductor. Springer, New York, NY.
25. Karatzoglou A, Smola A, Hornik K, Zeileis A. 2004. kernlab-an S4 package for kernel methods in R. J Stat Softw 11: 1-20.
26. Gaujoux R, Seoighe C. 2013. CellMix: a comprehensive toolbox for gene expression deconvolution. Bioinformatics 29: 2211-2212. http://dx.doi.org/10.1093/bioinformatics/btt351.
27. Shen-Orr SS, Tibshirani R, Khatri P, Bodian DL, Staedtler F, Perry NM, Hastie T, Sarwal MM, Davis MM, Butte AJ. 2010. Cell type-specific gene expression differences in complex tissues. Nat Methods 7: 287-289. http://dx.doi.org/10.1038/nmeth.1439.
28. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, Matud JL, Prince HE, Lanciotti RS, Wright DJ, Linnen JM, Caglioti S. 2008. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 198: 984-993. http://dx.doi.org/10.1086/591467.
29. Qian F, Bolen CR, Wang X, Jing C, Fikrig E, Bruce RD, Kleinstein SH, Montgomery RR. 2013. Impaired Toll-like receptor 3-mediated interferon responses from macrophages of patients chronically infected with hepatitisCvirus. Clin Vaccine Immunol 20: 146-155. http://dx.doi.org/10.1128/CVI.00530-12.
30. Yaari G, Bolen CR, Thakar J, Kleinstein SH. 2013. Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations. Nucleic Acids Res 41: e170. http://dx.doi.org/10.1093/nar/gkt660.
31. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ. 2009. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119: 3266-3277. http://dx.doi.org/10.1172/JCI39387.
32. Lanteri MC, Diamond MS, Law JP, Chew GM, Wu S, Inglis HC, Wong D, Busch MP, Norris PJ, Ndhlovu LC. 2014. Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection. PLoS One 9: e92134. http://dx.doi.org/10.1371/journal.pone.0092134.
33. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, James JJ, Maysuria M, Mitton JD, Oliveri P, Osborn JL, Peng T, Ratcliffe AL, Webster PJ, Davidson EH, Hood L, Dimitrov K. 2008. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26: 317-325. http://dx.doi.org/10.1038/nbt1385.
34. You F, Wang P, Yang L, Yang G, Zhao YO, Qian F, Walker W, Sutton RE, Montgomery RR, Lin R, Iwasaki A, Fikrig E. 2013. ELF4 is critical for induction of type I interferon and the host antiviral response. Nat Immunol 14: 1237-1246. http://dx.doi.org/10.1038/ni.2756.
35. Wang P, Dai J, Bai F, Kong KF, Wong SJ, Montgomery RR, Madri JA, Fikrig E. 2008. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol 82: 8978-8985. http://dx.doi.org/10.1128/JVI.00314-08.
36. Brass AL, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254. http://dx.doi.org/10.1016/j.cell.2009.12.017.
37. Bai F, Kong K-F, Dai J, Qian F, Zhang L, Brown CR, Fikrig E, Montgomery RR. 2010. A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis 202: 1804-1812. http://dx.doi.org/10.1086/657416.
38. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kB by Toll-like receptor 3. Nature 413: 732-738. http://dx.doi.org/10.1038/35099560.
39. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110: 3507-3512. http://dx.doi.org/10.1073/pnas.1222878110.
40. Cho H, Shrestha B, Sen GC, Diamond MS. 2013. A role for Ifit2 in restricting West Nile virus infection in the brain. J Virol 87: 8363-8371. http://dx.doi.org/10.1128/JVI.01097-13.
41. +T-cell recruitment and control of West Nile virus encephalitis. J Virol 79: 11457-11466. http://dx.doi.org/10.1128/JVI.79.17.11457-11466.2005.
42. Ramos HJ, Lanteri MC, Blahnik G, Negash A, Suthar MS, Brassil MM, Sodhi K, Treuting PM, Busch MP, Norris PJ, Gale M, Jr. 2012. IL-1beta signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog 8: e1003039. http://dx.doi.org/10.1371/journal.ppat.1003039.
43. Harikumar KB, Yester JW, Surace MJ, Oyeniran C, Price MM, Huang WC, Hait NC, Allegood JC, Yamada A, Kong X, Lazear HM, Bhardwaj R, Takabe K, Diamond MS, Luo C, Milstien S, Spiegel S, Kordula T. 2014. K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5. Nat Immunol 15: 231-238. http://dx.doi.org/10.1038/ni.2810.
44. Durrant DM, Robinette ML, Klein RS. 2013. IL-1R1 is required fordendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis. J Exp Med 210: 503-516. http://dx.doi.org/10.1084/jem.20121897.
45. Mechtcheriakova D, Wlachos A, Sobanov J, Kopp T, Reuschel R, Bornancin F, Cai R, Zemann B, Urtz N, Stingl G, Zlabinger G, Woisetschlager M, Baumruker T, Billich A. 2007. Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal 19: 748-760. http://dx.doi.org/10.1016/j.cellsig.2006.09.004.
46. Teijaro JR, Walsh KB, Rice S, Rosen H, Oldstone MB. 2014. Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc Natl Acad SciUSA111: 3799-3804. http://dx.doi.org/10.1073/pnas.1400593111.
47. Kumanogoh A, Shikina T, Suzuki K, Uematsu S, Yukawa K, Kashiwamura S, Tsutsui H, Yamamoto M, Takamatsu H, Ko-Mitamura EP, Takegahara N, Marukawa S, Ishida I, Morishita H, Prasad DV, Tamura M, Mizui M, Toyofuku T, Akira S, Takeda K, Okabe M, Kikutani H. 2005. Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice. Immunity 22: 305-316. http://dx.doi.org/10.1016/j.immuni.2005.01.014.
48. Murray K, Walker C, Herrington E, Lewis JA, McCormick J, Beasley DW, Tesh RB, Fisher-Hoch S. 2010. Persistent infection with West Nile virus years after initial infection. J Infect Dis 201: 2-4. http://dx.doi.org/10.1086/648731.
49. Tuncbilek S. 2014. Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection. World J Gastroenterol 20: 6226-6235. http://dx.doi.org/10.3748/wjg.v20.i20.6226.